Polymorphous light eruption: PUVA-induced skin hyporeactivity.
Eight patients with polymorphous light eruption (PLE) were treated with the 8-methoxypsoralen (0.6 mg/kg) and UV-A given in an ordinary PUVA cabin. Excellent or good results were observed in 4 and moderate in others remained patients. It is concluded that PUVA treatment is a safe form of therapy which exercises its beneficial effect in the patients with PLE. Various theories concerning the mode of action of photochemotherapy in PLE are discussed in this paper.
Nozicková
M
M
Department of Microbiology, Epidemiology and Dermatology, Faculty of Medicine, Charles University.
Ettler
K
K
D000328:Adult; D005260:Female; D006801:Humans; D008297:Male; D011701:PUVA Therapy; D010787:Photosensitivity Disorders / Q000188:drug therapy*